News, musings and commentary on dietary supplements & pharmaceutical law issues, technology, and litigation.
Lawyers for consumers and injured people.(No advice on this blog, though)
Friday, February 02, 2007
FDA Slaps Drug Co. Ad's Misleading
The FDA claims that MGI Pharma published a "misleading" advertisement for the company's implanted therapy to treat brain tumors.
A two-page promotional ad for the product, called gliadel wafer, does not disclose its full indication and presents unsubstantiated claims, according to the FDA.